Career level
Early career researcher
Mid-career researcher
Established independent researcher
Non-clinical researcher
Clinician
Research area
Early diagnosis
Final submission
18 September 2025
Committee review
November 2025
Funding period
Up to 1 year
Funding amount
Up to £100k
Supports researchers at all stages to develop early, novel and outside-the-box ideas and collaborations to build and make progress in the ED&D field.
Scientific remit
With this award, we're challenging you to consider how you can utilise skills and techniques in innovative ways to accelerate ED&D research. Primer Awards provide seed funding to develop new relationships, ideas and lines of research, and the generation of pilot data.
The award aims to encourage scientists at all career stages to engage with the early detection and diagnosis of cancer field. It will support new and exploratory research ideas and/or pilot studies of high scientific risk and potential reward. It supports the development of new partnerships and exploration of highly novel concepts, involving researchers from any research area, including from non-traditional cancer fields.
Areas that could be considered include:
Funding can contribute towards generating pilot data for a new and exciting idea, establishing and developing new collaborations, testing a new technology or using an existing technology in an innovative way. We envisage that data generated or collaborations established through a Primer Award will form the basis for a more extensive future project within ED&D.
Out of remit
Proposals for research in these fields are likely to be ineligible for this funding scheme:
If you are unsure which funding scheme is most appropriate for your research, please get in touch to discuss your proposal.
Early Detection and Diagnosis Research Committee
What is funded
The award will provide up to 1 year of flexible seed funding up to £100k. Funding could cover:
We are also giving applicants to this funding scheme the opportunity to opt-in to a new multi-journal pilot project on Registered Reports.
To stimulate and develop the early detection and diagnosis (ED&D) field, we're encouraging early-career researchers, scientists new to ED&D and/or cancer research, as well as established ED&D researchers to apply for Primer Awards.
You should:
Sponsor Institute/Organizations: Cancer Research UK
Sponsor Type: Corporate/Non-Profit
Address: 2 Redman Place, London, E20 1JQ.
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 18, 2025
Sep 18, 2025
$100,000
Affiliation: Cancer Research UK
Address: 2 Redman Place, London, E20 1JQ.
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.